Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.34 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.34 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.34 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.34 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.33 |
| ▸ | BDKRB2 known ✓ | P30411 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CASP2 | P42575 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 3/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18035807 | 0.98 | CHRM2 (0.35) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL6557911 | 0.93 | CHRM2 (0.38) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Bromide SCHEMBL1548089 | 0.89 | RAD52 (0.43) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Acetic Acid SCHEMBL15210170 | 0.87 | CA2 (0.34) | MAPK1ACHETSHR | |
| Bromide SCHEMBL9299877 | 0.85 | HSP90AA1 (0.31) | KMT2ASMN1; SMN2RAD52CHRM2ADRA2A | |
| Iodide SCHEMBL11381556 | 0.85 | — | — | |
| SCHEMBL16650419 | 0.78 | — | — | |
| Iodide SCHEMBL11395813 | 0.76 | — | — | |
| SCHEMBL11126349 | 0.73 | CHRM2 (0.33) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL13762473 | 0.71 | CHRM2 (0.41) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2638123-B1 | WORKING MEDIUM FOR ABSORPTION HEAT PUMPS | EVONIK DEGUSSA GMBH (DE) | 2016-08-31 | — | — | EP | claimed |
| US-20130219949-A1 | WORKING MEDIUM FOR ABSORPTION HEAT PUMPS | EVONIK DEGUSSA GMBH (DE) | 2013-08-29 | — | — | US | claimed |
| US-20130219949-A1 | WORKING MEDIUM FOR ABSORPTION HEAT PUMPS | EVONIK DEGUSSA GMBH (DE) | 2013-08-29 | — | — | US | disclosed |
| US-7652180-B2 | Process for preparing alkyl chlorides | DEGUSSA AG (DE) | 2010-01-26 | — | — | US | disclosed |
| US-20060205987-A1 | Process for preparing alkyl chlorides | DEGUSSA AG (DE) | 2006-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205987-A1 | Process for preparing alkyl chlorides | HACL2, ARL1, MGLL | CHRM2 754/4885CHRM1 424/4885ACHE 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.